LIGAND PHARMACEUTICALS INC
A biopharmaceutical firm that acquires royalty assets and licenses technology platforms.
LGND | US
Overview
Corporate Details
- ISIN(s):
- US53220K5048
- LEI:
- Country:
- United States of America
- Address:
- 3911 SORRENTO VALLEY BLVD, 92121 SAN DIEGO
- Website:
- https://www.ligand.com/
Description
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that functions as a capital and technology partner to the life sciences industry. The company's business model focuses on acquiring and developing royalty-generating assets by investing in the clinical development and commercialization of medicines. It manages a large, diverse portfolio of economic rights to partnered programs across therapeutic areas such as oncology, kidney disease, diabetes, and rare conditions. In addition to its royalty business, Ligand develops and licenses its proprietary technology platforms to a global network of biopharmaceutical partners. Its key technologies include Captisol®, a chemically modified cyclodextrin used to improve the solubility and stability of active pharmaceutical ingredients, and the NITRICIL™ platform.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-02-28 02:52 |
FORM 4 SUBMISSION
|
English | 7.6 KB | ||
| 2023-02-28 02:51 |
FORM 4 SUBMISSION
|
English | 7.5 KB | ||
| 2023-02-28 02:50 |
FORM 4 SUBMISSION
|
English | 7.6 KB | ||
| 2023-02-22 22:05 |
8-K
|
English | 195.3 KB | ||
| 2023-02-18 01:23 |
FORM 4 SUBMISSION
|
English | 6.8 KB | ||
| 2023-02-18 01:20 |
FORM 4 SUBMISSION
|
English | 6.7 KB | ||
| 2023-02-10 21:23 |
JHG PLC OWNS >5%
|
English | 13.1 KB | ||
| 2023-02-09 22:30 |
SC 13D/A
|
English | 17.6 KB | ||
| 2023-02-09 19:53 |
SC 13G/A
|
English | 14.6 KB | ||
| 2023-02-09 17:25 |
SCHEDULE 13G/A
|
English | 10.9 KB | ||
| 2023-02-06 21:18 | English | 9.6 KB | |||
| 2023-01-26 14:52 | English | 13.5 KB | |||
| 2023-01-20 23:17 | English | 13.5 KB | |||
| 2023-01-04 23:00 |
FORM 4 SUBMISSION
|
English | 6.7 KB | ||
| 2022-12-30 23:00 |
FORM 4 SUBMISSION
|
English | 6.6 KB |
Automate Your Workflow. Get a real-time feed of all LIGAND PHARMACEUTICALS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for LIGAND PHARMACEUTICALS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for LIGAND PHARMACEUTICALS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
